Exelixis



Ebitda Zmiana Data
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Exelixis USD 171.1M 24.2M 2025-01
Genmab DKK 2.23B 85M 2024-09
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 320.2M 128.19M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
MacroGenics USD 56.03M 112.4M 2024-09
Merck USD 7.12B 1.06B 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Sanofi EUR 4.49B 2.47B 2024-09
Takeda JPY 254.6B 125.66B 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Xencor USD 7.14M 64.97M 2024-12



Exelixis - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.